Journal Article

Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study

Maleckas, Almantas, Ignatavicius, Povilas, Parseliunas, Audrius, Kiudelis, Mindaugas, Endzinas, Zilvinas, Dambrauskas, Zilvinas, Mickevicius, Antanas, Markelis, Rytis, Butkute, Dainora

2014

Overview

Background A steady decline in gastric cancer mortality rate over the last few decades is observed in Western Europe. However it is still not clear if this trend applies to Eastern Europe where high incidence rate of gastric cancer is observed. Methods This was a retrospective non-randomized, single center, cohort study. During the study period 557 consecutive patients diagnosed with gastric cancer in which curative operation was performed met the inclusion criteria. The study population was divided into two groups according to two equal time periods: 01-01-1994 – 31-12-2000 (Group I – 273 patients) and 01-01-2001 – 31-12-2007 (Group II – 284 patients). Primary (five-year survival rate) and secondary (postoperative complications, 30-day mortality rate and length of hospital stay) endpoints were evaluated and compared. Results Rate of postoperative complications was similar between the groups, except for Grade III (Clavien-Dindo grading system for the classification of surgical complications) complications that were observed at significantly lower rates in Group II (26 (9.5%) vs. 11 (3.9%), p = 0.02). Length of hospital stay was significantly (p = 0.001) shorter (22.6 ± 28.9 vs. 16.2 ± 17.01 days) and 30-day mortality was significantly (p = 0.02) lower (15 (5.5%) vs. 4 (1.4%)) in Group II. Similar rates of gastric cancer related mortality were observed in both groups (92.3% vs. 90.7%). However survival analysis revealed significantly (p = 0.02) better overall 5-year survival rate in Group II (35.6%, 101 of 284) than in Group I (23.4%, 64 of 273). There was no difference in 5-year survival rate when comparing different TNM stages. Conclusions Gastric cancer treatment results remain poor despite decreasing early postoperative mortality rates, shortening hospital stay and improved overall survival over the time. Prognosis of treatment of gastric cancer depends mainly on the stage of the disease. Absence of screening programs and lack of clinical symptoms in early stages of gastric cancer lead to circumstances when most of the patients presenting with advanced stage of the disease can expect a median survival of less than 30 months even after surgery with curative intent.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V
• Subject: Adenocarcinoma - mortality / Adenocarcinoma - pathology / Adenocarcinoma - surgery / Aged / Analysis / Biomedical research / Cancer therapies / Care and treatment / Chemotherapy / Classification / Diagnosis / Dissection / Drug therapy / Europe, Eastern - epidemiology / Female / Gastrectomy / Gastric cancer / Health aspects / Health sciences / Hospital Mortality / Hospitals / Humans / Internal Medicine / Length of Stay / Male / Medical prognosis / Medicine / Medicine & Public Health / Methods / Mortality / Neoplasm Staging / Postoperative Complications - epidemiology / Postoperative period / Research Article / Retrospective Studies / Statistical analysis / Stomach cancer / Stomach Neoplasms - mortality / Stomach Neoplasms - pathology / Stomach Neoplasms - surgery / Studies / Surgery / Surgical outcomes / Survival Analysis / Survival Rate / Treatment Outcome / Trends / Visceral and general surgery